Showing results (51-60 of 81) with videos related to
Sort By:
Pageof 9
Journal of Viral Hepatitis|January 24, 2004
High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapyS Zhong, W Yeo, C Schroder, et al.Investigational New Drugs|November 27, 2002
A randomized phase II study of two schedules of bryostatin-1 (NSC339555) in patients with advanced malignant melanoma: A National Cancer Institute of Canada Clinical Trials Group studyR G Tozer, S Burdette-Radoux, K Berlanger, et al.International Journal of Radiation Oncology, Biology, Physics|January 15, 1994
Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancerP Coy, D I Hodson, N Murray, et al.British Journal of Cancer|September 23, 1998
Randomized study of chemotherapy and surgery versus radiotherapy for stage IIIA non-small-cell lung cancer: a National Cancer Institute of Canada Clinical Trials Group StudyF A Shepherd, M R Johnston, D Payne, et al.Cancer|August 10, 2000
A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinomaT S Mok, B Zee, A T Chan, et al.The Journal of Rheumatology|November 1, 1993
Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studiesP J Clements, P A Lachenbruch, J R Seibold, et al.Journal of Medical Virology|October 31, 2000
Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factorsW Yeo, P K Chan, S Zhong, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 2, 2006
Role of laboratory variables in differentiating SARS-coronavirus from other causes of community-acquired pneumonia within the first 72 h of hospitalizationN Lee, T H Rainer, M Ip, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2007
A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicityT S K Mok, W Yeo, P J Johnson, et al.The British Journal of Radiology|March 18, 2008
The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosisA D King, B B Ma, Y Y Yau, et al.Pageof 9